Search Results
Jun 17, 2026, 09:09 ET VahatiCor Enrolls First U.S. Patient in SERRA-I Clinical Study of A-FLUX Reducer System® for CMD
broader SERRA clinical program, with centers across the U.S. and EU. The first U.S. patient was enrolled at Yale-New Haven Hospital, with Samit Shah, MD, PhD, an interventional cardiologist with Yale New Haven Hospital Heart & Vascular Center and assistant professor of medicine at Yale School of Medicine,
More news about: VahatiCor, Inc.
Jun 17, 2026, 09:09 ET VahatiCor Enrolls First U.S. Patient in SERRA-I Clinical Study of A-FLUX Reducer System® for CMD
broader SERRA clinical program, with centers across the U.S. and EU. The first U.S. patient was enrolled at Yale-New Haven Hospital, with Samit Shah, MD, PhD, an interventional cardiologist with Yale New Haven Hospital Heart & Vascular Center and assistant professor of medicine at Yale School of Medicine,
More news about: VahatiCor, Inc.
Jun 17, 2026, 09:09 ET VahatiCor recrute son premier patient américain dans le cadre de l'étude clinique SERRA-I portant sur le système A-FLUX Reducer System® pour le traitement de la CMD
centres répartis aux États-Unis et dans l'Union européenne. Le premier patient américain a été recruté à l'hôpital Yale-New Haven ; le Dr Samit Shah, MD, PhD, cardiologue interventionnel au Centre cardiovasculaire de l'hôpital Yale-New Haven et maître de conférences en médecine à la faculté de médecine de
More news about: VahatiCor, Inc.
Jun 17, 2026, 09:09 ET VahatiCor nimmt ersten US-Patienten in die klinische Studie SERRA-I zum A-FLUX Reducer System® bei CMD auf
den USA und der EU beteiligt sind. Der erste US-amerikanische Patient wurde im Yale-New Haven Hospital in die Studie aufgenommen. Dr. med. Samit Shah, PhD, interventioneller Kardiologe am Yale New Haven Hospital Heart & Vascular Center und Assistenzprofessor für Medizin an der Yale School of Medicine,
More news about: VahatiCor, Inc.
Jun 17, 2026, 09:00 ET A Race Against Blindness Commits $1 Million to Advance Gene-Agnostic Therapeutic Approaches
Mendel's work is mentored by Andy J. Fischer, PhD, and Cagri Besirli, MD, PhD."Some of the most powerful ideas in our field are the broad-reaching ones that can help many patients across the spectrum of inherited retinal diseases," said Amy Laster, PhD, chief scientific officer of the Foundation
More news about: Foundation Fighting Blindness
Jun 17, 2026, 09:00 ET 10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
collaboration has the potential to shed new light into the mechanisms underlying therapeutic response in a number of major cancer types," said Timothy Chan, MD, PhD, Chair, Department of Cancer Sciences, Cleveland Clinic.The study is expected to include tumor samples from patients treated with antibody-drug
More news about: 10x Genomics, Inc.
Jun 17, 2026, 09:00 ET New Proof-of-Concept Study Explores Acute Cognitive Benefits of Cognizin®
Focus: Acute Cognizin® Effects on Brain Activity and Cognitive Performance." The session will be presented by Emerson and Tim N. Ziegenfuss, PhD, CSCS, FISSN, CEO of The Center for Applied Health Sciences and Past President of ISSN.For formulators and brand owners evaluating ingredient
More news about: Kyowa Hakko U.S.A
Jun 17, 2026, 09:00 ET Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics
first-in-human dosing is a major step forward, as well as the first clinical milestone in our collaboration with Hygtia Therapeutics," said Feng Ren, PhD, Co-CEO and Chief Scientific Officer of Insilico Medicine. "Developing an effective NLRP3 inhibitor that can safely penetrate the blood-brain barrier
More news about: Insilico Medicine
Jun 17, 2026, 08:01 ET Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
trademark of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA.Nectin Contact:Keren Paz, PhDChief Development [email protected]+1
More news about: Nectin Therapeutics, LTD.
Jun 17, 2026, 08:01 ET Virginia Cancer Specialists Announces 21 Physicians Named to Washingtonian "Top Doctors" Hall of Fame
Alexander I. Spira, MD, PhD, FACP, FASCO, Medical Oncologist
More news about: Virginia Cancer Specialists
Jun 17, 2026, 07:23 ET ERMProtect Announces Strategic Partnership with NimbusDDOS to Expand DDoS Resilience Testing Services
outsourcing, and on-demand security consulting. The company's training division offers a 100+ module library of Security Awareness Training and in-person, PhD-led sessions that teach organizations how to protect data and incorporate better security.Learn more at
More news about: ERMProtect
Jun 17, 2026, 05:00 ET CHOP Scientists Engineer Personalized Cartilage Graft for Infants with Life-Threatening Airway Narrowing
Riccardo Gottardi, PhD, Assistant Professor with the Perelman School of Medicine at the University of Pennsylvania and leader of the Bioengineering and Biomaterials (Bio2)
More news about: Children's Hospital of Philadelphia
Jun 16, 2026, 16:29 ET Sun Life and Medzown team up to expand access to clinical trials for cancer and other complex diseases
platform integrates molecular, clinical, and claims data to match patients with appropriate therapies and clinical trials, with each case reviewed by PhD scientists and supported by personal navigators who work directly with patients and their physicians. Learn more at Medzown.com.Media ContactsDevon
More news about: Sun Life U.S.
Jun 16, 2026, 13:50 ET Marquis Who's Who Recognizes Todd G. Fritch, PhD, for Leadership in Higher Education
/PRNewswire/ -- Marquis Who's Who recognizes Todd G Fritch, PhD, for his leadership in higher education and his commitment to expanding access through transformative institutional growth. As president of the University
More news about: Marquis Who's Who
Jun 16, 2026, 12:19 ET Oracle's Dr. Sanjay Basu Confirmed to Speak at TCW LIVE! Panel on the Future of AI Infrastructure
Oracle. Basu holds a doctorate in organizational behavior and a double master's in management and computer engineering. He is working on his second PhD in AI and Quantum AI Agents. He is a life member of ACM, AAAI, AAAS, and IEEE, and a fellow of IETE. He is a prolific writer and author of technical
More news about: Connectbase
Jun 16, 2026, 11:00 ET Octen Achieves Top Global Rankings in AI Benchmarking for Deep Research
DeepResearch Bench evaluates whether AI systems can reason across multiple sources, synthesize complex information, and produce structured, PhD-level research reports under realistic academic conditions. It has become the standard evaluation ground for most major systems in this category, including
More news about: Octen
Jun 16, 2026, 11:00 ET Clinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIA
medicine."This is an important proposal that will hopefully spark crucial conversations across the clinical laboratory community," said Jonathan Genzen, MD, PhD, MBA, chief medical officer and senior director of governmental affairs. "I'm personally grateful that a physician member of Congress introduced this
More news about: ARUP Laboratories
Jun 16, 2026, 10:08 ET Inflammatix Collaborates with University of Nebraska Medical Center to Support Rapid Response to the Hantavirus Outbreak Using TriVerity®
discharge disposition.TriVerity® was developed based on research conducted at Stanford University by co-founders Tim Sweeney, MD, PhD, and Purvesh Khatri, PhD. Inflammatix holds exclusive rights to the core intellectual property. About InflammatixInflammatix, Inc., based in
More news about: Inflammatix
Jun 16, 2026, 09:30 ET Akston's AKS-699 Demonstrates Pruritus Control Sustained Through One Year, Comparable to lokivetmab with Fewer Treatments, in Head-to-Head Canine IL-31 Challenge Study
durable control of IL-31 challenge associated pruritus comparable to that of lokivetmab with substantially reduced dosing frequency. Todd Zion, PhD, co-founder and CEO of Akston commented, "For pet parents managing their dog's atopic dermatitis, the treatment burden is real; requiring frequent, routine,
More news about: Akston Biosciences
Jun 16, 2026, 09:30 ET Clinical Trials on Alzheimer's Disease Conference and Alzheimer's Drug Discovery Foundation Partner to Advance Emerging Biotech Innovation at CTAD 2026
patients.""The progress we are seeing across the Alzheimer's pipeline makes rigorous clinical development more important than ever," said Jacques Touchon, MD, PhD, Co-Founder and Co-Chairman of CTAD. "As the field moves toward more targeted and ultimately more personalized approaches, it is critical that we help
More news about: Alzheimer's Drug Discovery Foundation
Jun 16, 2026, 09:18 ET Paskenta Band of Nomlaki Indians and OATI Partner to Bring Energy Sovereignty and Stability to Tribal Lands in Northern California
private servers have safeguarded the energy industry's data.OATI was founded in 1995 by world-renowned power systems engineer Dr. Sasan Mokhtari, PhD. Privately owned for more than 30 years, OATI is an engineering-first organization that prides itself on leading the industry's most robust research
More news about: Open Access Technology International, Inc. (OATI)
Jun 16, 2026, 09:03 ET Adam & Eve Marks National Sex Education Month With Survey On Bedroom Confidence
comes to sexual confidence and communication."Sexual confidence isn't something most people simply have or don't have," says Dr. Jenni Skyler, PhD, LMFT, C-PST, and Adam & Eve's resident sex therapist. "It's something that develops through education, communication, self-awareness and experience.
More news about: Adam & Eve
Jun 16, 2026, 09:00 ET ADA Forsyth Institute selects PDS Health Technologies to implement Epic platform at Forsyth Faculty Associates
medical-dental integration by implementing Epic, a platform optimized for integrating dental and overall health," said ADA Forsyth CEO Wenyuan Shi, PhD. "This work will help strengthen patient care at Forsyth Faculty Associates while also supporting our mission to advance oral health, overall health
More news about: PDS Health
Jun 16, 2026, 08:00 ET Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets
sensing-based technology. I look forward to working with the Nervonik team in advancing this approach to help chronic pain patients."Aydin Babakhani, PhD, founder and CEO of Nervonik, stated, "Demonstrating neural sensing in chronic pain patients is a major milestone for Nervonik. Our ability to record
More news about: Nervonik Inc.
Jun 16, 2026, 08:00 ET Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference
treatment of patients with C. difficile infection (CDI). The Company today announced that a presentation was given by Mia Urem, PhD, from Leiden University Medical Center in the Netherlands entitled: "A unique inhibitor conformation selectively targets Gram+ Bacterial DNA Replication"
More news about: Acurx Pharmaceuticals, Inc.